CBD and THC aren’t the only cannabis compounds that provide relief
As studies into cannabis continue to advance, more is being learned about the different compounds and the effect they have, either individually or in tandem, in fighting a number of diseases and ailments. Over 60 cannabinoids have been identified so far and one is just now beginning to receive a considerable amount of attention. Cannabigerol (CBG) is a non-psychoactive compound found in cannabis that is showing more promise because of its medicinal value.
CBG is also known as the “stem cell” or “parent” of other cannabis cannabinoids. It is the non-acidic form of CBGA, the parent molecule that produces several other cannabinoids. By the time a cannabis plant matures, most of the CBG has been converted into CBGA and, therefore, into other cannabinoids.
CBG is not only non-psychoactive, but it is also non-intoxicating. It is able to act on the central nervous system without creating the “high” feeling and it contains anti-septic, anti-microbial and anti-bacterial properties that make it extremely versatile as a medicine. It has also been shown to fight Methicillin-resistant Staphylococcus aureus (MRSA), which can lead to staph infections that are difficult to treat.
CBG has also been shown to be able to slow the growth of cancer cells and tumors. There have also been studies that identify the cannabinoid to be effective in treating Huntington ’s disease, as well as other neurodegenerative disorders.
A report from 2016 identified CBG as an effective treatment for anxiety and depression. It is able to block serotonin receptors and can inhibit the brain’s GABA, the amino acid that serves as a neurotransmitter within the central nervous system. Inhibiting GABA helps to reduce anxiety and muscle tension.
There is still much to be studied on all the cannabis compounds, but what has been shown so far, over the past 20 years or so, is startling. It’s no surprise that cannabis is Mother Nature’s wonder drug.